Growth in the Lipid Nanoparticles (LNPs) market is driven by increasing demand for mRNA-based therapeutics and advances in delivery systems.…
Biontech und Moderna erzielten Milliardengewinne mit Impfstoffen. Inzwischen ist das Boomgeschäft eingebrochen – und die Strategien driften auseinander. Während Moderna…
Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended…
Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates.…
…
Earnings call transcript: Moderna Q2 2025 beats forecasts, stock dips…
Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares fell almost 9% in early trade as the pharmaceutical giant lowered its full-year guidance and…
Während der Corona-Pandemie benötigt der Pharmakonzern Moderna viele zusätzliche Angestellte, um mit der Impfstoffentwicklung und -produktion nachzukommen. Jetzt ebbt die…
In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by…
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find themselves on different…
Moderna to cut 10% of global workforce, CEO Bancel says…
Moderna ist ein US-amerikanisches Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das sich auf die Entwicklung von mRNA-basierten Therapien und Impfstoffen…
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.…
In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.…
Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans…
…
Key PointsThis stock used to be a highflyer but has struggled in recent years as demand waned for its flagship…
The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.…
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months…
Moderna stock rating reiterated at Buy by Brookline Capital Markets…
Key PointsModerna has a deep pipeline of promising mRNA candidates that stand to boost business.Regeneron is looking at label expansions…
Key PointsAfter soaring in early pandemic days, Moderna has fallen into the doldrums. An explosive phase of growth may be…
Key PointsThe company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine.This might…
Düsseldorf (www.aktiencheck.de) - Moderna-Chartanalyse von HSBC Trinkaus & Burkhardt:
Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse…
Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvias reach.…
Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars…
The S&P 500 and Nasdaq added to their all-time highs at midday as investors anticipated more U.S. trade agreements ahead.…
The phase three study data clears the path forward for Modernas combination jab targeting Covid-19 and influenza.…
In the closing of the recent trading day, Moderna (MRNA) stood at $27.54, denoting a +2.53% move from the preceding…
In the most recent trading session, Moderna (MRNA) closed at $25.90, indicating a +1.97% shift from the previous trading day.…
…
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects…
Modernas shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the…
US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults…
…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
Nächster Paukenschlag in den USA: Gesundheitsminister Robert F. Kennedy Jr. hat alle Mitglieder eines Gremiums (ACIP) von Impfexperten der US-…
Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul…
…
Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says…
FDA grants limited approval to Moderna’s new mRNA COVID vaccine…
…
These are the stocks posting the largest moves in the premarket.…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares edged higher after the US Food and Drug Administration (FDA) approved its newest COVID-19 vaccine…
The U.S. approved a new Covid-19 vaccine made by Moderna but with limits on who can use it — not…